Literature DB >> 31876584

Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases.

Elizabeth N Pavlisko1, Beiyu Liu2, Cindy Green2, Thomas A Sporn1, Victor L Roggli1.   

Abstract

We reviewed 354 cases of malignant diffuse mesothelioma (MM) in women from a database of 2858 histologically confirmed MM cases. There was a pleural predominance with 78% pleural MM and 22% peritoneal MM. The pleural tumors consisted of 72% epithelioid, 19% biphasic, and 9% sarcomatoid variant. The peritoneal tumors consisted of 82% epithelioid, 13% biphasic, and 5% sarcomatoid. The immunohistochemical profile was typical of what is well-accepted and previously described for MM. When examining tumor subtype and location, there was a trend toward epithelioid subtype and peritoneal location; however, this did not reach statistical significance. Age at the time of diagnosis ranged from 19 to 93 years with a mean of 60 years. The median age at time of diagnosis for pleural MM was 65 years and for peritoneal MM was 52 years. A further look at age and histologic subtype showed no statistically significant difference in age between MM subtypes. Survival was greatest for epithelioid variant, and this was magnified in the peritoneum. A majority of our cases were exposed to asbestos through a household contact. Asbestosis and parietal pleural plaque were present in 5% and 50% of cases with data, respectively. Fiber analysis data was available in 67 cases; 38 cases had elevated asbestos fiber burden, and tremolite was the most common asbestos fiber type detected. Commercial and noncommercial amphibole asbestos fibers were elevated in nearly equal numbers of cases.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31876584     DOI: 10.1097/PAS.0000000000001418

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.

Authors:  David B Chapel; Jefree J Schulte; Gudrun Absenger; Richard Attanoos; Luka Brcic; Kelly J Butnor; Lucian Chirieac; Andrew Churg; Françoise Galateau-Sallé; Kenzo Hiroshima; Yin P Hung; Hedy Kindler; Thomas Krausz; Alberto Marchevsky; Mari Mino-Kenudson; Jeffrey Mueller; Kazuki Nabeshima; Kirin Turaga; Ann E Walts; Aliya N Husain
Journal:  Mod Pathol       Date:  2020-10-15       Impact factor: 7.842

Review 2.  Molecular Pathways in Peritoneal Mesothelioma: A Minireview of New Insights.

Authors:  Francesco Fortarezza; Federica Pezzuto; Andrea Marzullo; Domenica Cavone; Daniele Egidio Romano; Antonio d'Amati; Gabriella Serio; Luigi Vimercati
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

3.  A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma.

Authors:  Xiao Wang; Sharyn Katz; John Miura; Giorgos Karakousis; Leonid Roshkovan; Suzanne Walker; Sally McNulty; Christine Ciunci; Keith Cengel; Corey J Langer; Melina E Marmarelis
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

Review 4.  The role of gender in non-small cell lung cancer: a narrative review.

Authors:  Ioana Baiu; Ashley L Titan; Linda W Martin; Andrea Wolf; Leah Backhus
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

5.  Ongoing downplaying of the carcinogenicity of chrysotile asbestos by vested interests.

Authors:  Xaver Baur; Arthur L Frank
Journal:  J Occup Med Toxicol       Date:  2021-02-23       Impact factor: 2.646

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.